family with sequence similarity 207 member C, pseudogeneGenealiases: []
Q-omics provides the consensus-scored FAM207CP profile across patient tissues and cancer cell-line models. FAM207CP expression is associated with patient survival in 10 of 34 cancer types, with the highest sampling consensus in PAAD. Among the 18 cancer types available for tumor–normal comparison, FAM207CP is differentially expressed in 1, with the highest sampling consensus in KIRC. Additionally, FAM207CP RNA expression shows 3,055 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight PAAD, KIRC, and TGCT as cancer lineages where FAM207CP shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for FAM207CP — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes FAM207CP survival associations across molecular data types. FAM207CP RNA expression shows survival associations in the most cancer types (10). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible FAM207CP RNA expression–survival associations across cancer types. High FAM207CP expression shows unfavorable associations in PAAD, UCEC, DLBC, KIRC, LUAD and ACC. The PAAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify PAAD as the clearest survival context for FAM207CP RNA expression.
This table summarizes FAM207CP tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for FAM207CP. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. FAM207CP shows higher tumor expression in KIRC. The KIRC box plot shows higher FAM207CP RNA expression in tumor versus normal tissue (log2 FC = +0.009, t-test p = .045).
This table shows molecular features associated with FAM207CP in patient tissues and cancer cell lines. In patient samples, FAM207CP shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
